FI77048B - Foerfarande foer framstaellning av en blodkoagulationsbefraemjande preparation pao basis av humanproteiner. - Google Patents

Foerfarande foer framstaellning av en blodkoagulationsbefraemjande preparation pao basis av humanproteiner.

Info

Publication number
FI77048B
FI77048B FI812295A FI812295A FI77048B FI 77048 B FI77048 B FI 77048B FI 812295 A FI812295 A FI 812295A FI 812295 A FI812295 A FI 812295A FI 77048 B FI77048 B FI 77048B
Authority
FI
Finland
Prior art keywords
preparation
humanproteiner
blodkoagulationsbefraemjande
foerfarande foer
foer framstaellning
Prior art date
Application number
FI812295A
Other languages
English (en)
Other versions
FI77048C (fi
FI812295L (fi
Inventor
Johann Eibl
Otto Schwarz
Fritz Elsinger
Anton Philapitsch
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI812295L publication Critical patent/FI812295L/fi
Application granted granted Critical
Publication of FI77048B publication Critical patent/FI77048B/fi
Publication of FI77048C publication Critical patent/FI77048C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI812295A 1980-07-22 1981-07-22 Foerfarande foer framstaellning av en blodkoagulationsbefraemjande preparation pao basis av humanproteiner. FI77048C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0378180A ATA378180A (de) 1980-07-22 1980-07-22 Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
AT378180 1980-07-22

Publications (3)

Publication Number Publication Date
FI812295L FI812295L (fi) 1982-01-23
FI77048B true FI77048B (fi) 1988-09-30
FI77048C FI77048C (fi) 1989-01-10

Family

ID=3555339

Family Applications (1)

Application Number Title Priority Date Filing Date
FI812295A FI77048C (fi) 1980-07-22 1981-07-22 Foerfarande foer framstaellning av en blodkoagulationsbefraemjande preparation pao basis av humanproteiner.

Country Status (17)

Country Link
US (1) US4395396A (fi)
AR (1) AR227194A1 (fi)
AT (2) ATA378180A (fi)
BE (1) BE889640A (fi)
CH (1) CH646061A5 (fi)
DE (1) DE3127318A1 (fi)
DK (1) DK155500C (fi)
ES (1) ES504000A0 (fi)
FI (1) FI77048C (fi)
FR (1) FR2487199A1 (fi)
GB (1) GB2080312B (fi)
HU (1) HU188298B (fi)
IT (1) IT1142032B (fi)
LU (1) LU83499A1 (fi)
NL (1) NL190268C (fi)
NO (1) NO157245C (fi)
SE (1) SE460174B (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE36457T1 (de) * 1983-05-02 1988-09-15 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen krankheitserregern.
AT379510B (de) * 1983-05-20 1986-01-27 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation
GB8403473D0 (en) * 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4710381A (en) * 1984-05-22 1987-12-01 The Blood Center Of Southeastern Wisconsin Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
ES2045167T5 (es) * 1987-10-23 1996-07-01 Centre Regional De Transfusion Preparacion de concentrado de factor ix humano de elevada pureza y de otras proteinas plasmaticas.
FR2622108B1 (fr) * 1987-10-23 1990-03-02 Lille Transfusion Sanguine Preparation de concentres de proconvertine (facteur vii), de facteur antihemophilique b (facteur ix) et d'autres proteines plasmatiques, et leur utilisation therapeutique
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
AT395597B (de) * 1991-01-25 1993-01-25 Immuno Ag Reagens zur bestimmung von faktor viii-aktivitaet
DK0573605T3 (da) 1991-03-01 2001-01-02 Rhone Poulenc Rorer Int Fremstilling af faktor IX
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
FR2711371B1 (fr) * 1993-10-18 1995-12-29 Aetsrn Procédé de préparation d'un concentré d'inter-alpha-trypsine inhibiteur à usage thérapeutique et concentré obtenu.
DE4416166C2 (de) * 1994-05-06 1997-11-20 Immuno Ag Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
SI0796623T1 (en) * 1996-03-20 2005-10-31 Baxter Aktiengesellschaft Pharmaceutical preparation for the treatment of blood coagulation disorders
ES2160410T3 (es) 1997-04-08 2001-11-01 Baxter Ag Preparados de complejos de protrombina inmunotolerantes.
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
AT405485B (de) * 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
AT411997B (de) 1999-09-14 2004-08-26 Baxter Ag Faktor ix/faktor ixa aktivierende antikörper und antikörper-derivate
JP4199004B2 (ja) 2000-11-07 2008-12-17 クライオライフ、インコーポレイテッド 起泡性泡沫様生体材料および方法
ES2325956T3 (es) * 2002-07-23 2009-09-25 BIO & BIO LICENSING SA Farmacos y preparaciones de principios activos farmaceuticas que contienen trombina y que pueden generar trombina.
RS20050051A (en) * 2002-07-23 2007-06-04 Bio-Products & Bio Engineering Ag., Pharmaceutical active ingredient preparation and medicaments that contain thrombin or have a thrombin-generating capacity
US7297336B2 (en) 2003-09-12 2007-11-20 Baxter International Inc. Factor IXa specific antibodies displaying factor VIIIa like activity
US20140206844A1 (en) 2013-01-18 2014-07-24 Prothera Biologics Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material
RU2648517C1 (ru) * 2017-06-23 2018-03-26 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Способ получения лиофилизированного препарата активированного протромбинового комплекса, обладающего фактор viii-шунтирующей активностью

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1492108A1 (de) 1964-05-04 1969-10-02 Rohm & Haas Verfahren zur Entfernung von Viren aus Blut waehrend der Entnahme oder UEbertragung
DE2262520C3 (de) * 1972-12-20 1987-02-12 Miles Laboratories, Inc., Elkhart, Ind. Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma
US4170590A (en) * 1974-12-14 1979-10-09 Biotest-Serum-Institut Gmbh Ion exchanger treatment of citrate-stabilized plasma
JPS52125609A (en) 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
US4081432A (en) 1977-07-25 1978-03-28 Monsanto Company Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
EP0044343B1 (en) * 1980-01-28 1984-08-22 Baxter Travenol Laboratories, Inc. Prothrombin-containing therapeutic compositions and methods of producing enzymatically active blood clotting factors from prothrombin-containing blood fractions
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them

Also Published As

Publication number Publication date
DK155500C (da) 1989-08-07
AR227194A1 (es) 1982-09-30
LU83499A1 (de) 1981-10-29
IT8123070A0 (it) 1981-07-22
DE3127318C2 (fi) 1988-07-28
GB2080312A (en) 1982-02-03
AT368883B (de) 1982-11-25
ES8203610A1 (es) 1982-04-16
DE3127318A1 (de) 1982-04-15
US4395396A (en) 1983-07-26
FI77048C (fi) 1989-01-10
FI812295L (fi) 1982-01-23
NO157245C (no) 1988-02-24
ES504000A0 (es) 1982-04-16
CH646061A5 (de) 1984-11-15
NL190268B (nl) 1993-08-02
SE8103759L (sv) 1982-01-23
SE460174B (sv) 1989-09-18
FR2487199B1 (fi) 1984-11-16
ATA378180A (de) 1982-04-15
NO157245B (no) 1987-11-09
FR2487199A1 (fr) 1982-01-29
HU188298B (en) 1986-03-28
DK155500B (da) 1989-04-17
NL190268C (nl) 1994-01-03
NL8103329A (nl) 1982-02-16
DK318581A (da) 1982-01-23
BE889640A (fr) 1981-11-03
NO812500L (no) 1982-01-25
GB2080312B (en) 1983-12-21
IT1142032B (it) 1986-10-08

Similar Documents

Publication Publication Date Title
FI77048B (fi) Foerfarande foer framstaellning av en blodkoagulationsbefraemjande preparation pao basis av humanproteiner.
KR860002567A (ko) 혈액응고 억제 단백질의 제조방법
DE3263450D1 (en) Process for the purification of blood coagulation factors ii, vii, ix and/or x and preparations manufactured accordingly
DE3382834D1 (de) Sorbentmittel und dessen Herstellungsverfahren
SE8802781L (sv) Foerfarande foer avfuktning av gaser
ATE296839T1 (de) Antikörper zur krebsbehandlung und -diagnose
FI892006A (fi) Lactalbumin saosom tillaeggsaemne i mat.
EP0111999A3 (en) Spherical ion exchange resin, method for producing the same and method for adsorption treatment using the same
GB2100601B (en) An aromatase-inhibitor for use in a method of prophylaxis and/or of treatment by therapy of prostatic hyperplasia, and pharmaceutical preparations suitable for such a use.
EP0325225A3 (en) Concentrates of coagulation factors ii, vii, ix and/or x, their preparation and use, and method for the determination of coagulation factor vii
DK292090D0 (da) Fremgangsmaade til fremstilling af et antithrombin iii-koncentrat
PT77019B (de) Mittel zur behandlung von wunden
PT91953A (pt) Processo para a preparacao de solucoes de antigenes contendo hidroxido de zinco ou hidroxido de ferro como agente auxiliar
DE58907555D1 (de) Verfahren zur Anreicherung der Blutgerinnungsfaktoren II, VII, IX und X.
EP0317085A3 (en) Processed red blood cells and process for producing the same
ES502084A0 (es) Procedimiento para tratar fracciones individuales de plasma sanguineo.
KR870700283A (ko) 온실 및 다른 차폐실의 대기를 처리하는 방법과 그 방법을 수행하기 위한 장치
EP0350738A3 (de) (S)-Emopamil zur Anwendung bei der Behandlung von Migräne
DK0590046T3 (da) Basiske acceleratoropløsninger til direkte elektroplettering
AU4930885A (en) A process for the purification and pasteurization of urokinase
EP0223770A3 (en) Mask to be charged with particles or rays, and process for producing the same
DE3686684D1 (de) Mittel zur absorptionsverbesserung von proteinen.
DK494384D0 (da) Fremgangsmaade til at forsinke gel-dannelsen af vandige polymeroploesninger, polymeroploesninger frembragt ved fremgangsmaaden samt anvendelse af saadanne polymeroploesninger ved behandling af oliekilder
ATE32472T1 (de) Methode und system zur krafterzeugung und zur erzeugung von gesaettigtem oder beinahe gesaettigtem niederdruckdampf.
JPS53114780A (en) Desalting method by ion exchange

Legal Events

Date Code Title Description
MA Patent expired

Owner name: "IMMUNO" AKTIENGESELLSCHAFT FUER